Home » CELLEGY REPORTS 2005 FINANCIAL RESULTS
CELLEGY REPORTS 2005 FINANCIAL RESULTS
Cellegy Pharmaceuticals, Inc. announced its 2005 financial results today. Net loss for the years ended December 31, 2005 and 2004 were $5,007,639 ($.18 per share) and $28,154,062 ($1.28 per share), respectively, with revenues of $12,835,345 and $2,596,377, respectively. Research expenses were $8,481,105 and $9,599,310 in 2005 and 2004, respectively, and selling, general and administrative expenses were $9,248,820 and $6,641,205. Black Enterprise (http://www.blackenterprise.com/yb/ybopen.asp?section=ybbf&story_id=91266997&ID=blackenterprise)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May